What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
David S. Alberts mainly investigates Internal medicine, Pharmacology, Oncology, Chemotherapy and Surgery.
His studies deal with areas such as Gastroenterology and Endocrinology as well as Internal medicine.
His Pharmacology research incorporates elements of Catechin, Epigallocatechin gallate, In vivo and Doxorubicin.
The study incorporates disciplines such as Peripheral neuropathy, Cancer and Interim analysis in addition to Oncology.
His Chemotherapy study incorporates themes from Regimen, Anesthesia and Metastatic breast cancer.
His Surgery study combines topics from a wide range of disciplines, such as Toxicity and Urology.
His most cited work include:
- Molecular classification of cutaneous malignant melanoma by gene expression profiling (1861 citations)
- Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix (1577 citations)
- Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer (1012 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Oncology, Pharmacology, Chemotherapy and Cancer.
His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Surgery.
His study in Oncology is interdisciplinary in nature, drawing from both Regimen, Disease, Cisplatin and Group study.
His research investigates the connection between Pharmacology and topics such as In vivo that intersect with problems in In vitro.
His Chemotherapy research includes elements of Nausea and Vomiting.
His work focuses on many connections between Cancer and other disciplines, such as Pathology, that overlap with his field of interest in Karyometry and Skin cancer.
He most often published in these fields:
- Internal medicine (42.78%)
- Oncology (24.11%)
- Pharmacology (18.39%)
What were the highlights of his more recent work (between 2009-2021)?
- Internal medicine (42.78%)
- Oncology (24.11%)
- Cancer (14.44%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Oncology, Cancer, Ovarian cancer and Pathology.
Clinical trial, Randomized controlled trial, Colorectal adenoma, Colorectal cancer and Gynecologic oncology are the core of his Internal medicine study.
Randomized controlled trial is a subfield of Surgery that David S. Alberts studies.
His work deals with themes such as Bevacizumab, Chemotherapy, Cisplatin, Regimen and Disease, which intersect with Oncology.
His Cancer research is multidisciplinary, incorporating elements of Melanoma, Pharmacology and Family medicine.
Alternative medicine is closely connected to Gynecology in his research, which is encompassed under the umbrella topic of Ovarian cancer.
Between 2009 and 2021, his most popular works were:
- The national lung screening trial: Overview and study design (715 citations)
- Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study (210 citations)
- Clinical trials in recurrent ovarian cancer. (130 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
David S. Alberts mostly deals with Internal medicine, Oncology, Randomized controlled trial, Ovarian cancer and Clinical trial.
His work on Placebo expands to the thematically related Internal medicine.
His biological study spans a wide range of topics, including Bevacizumab, Chemotherapy regimen, Chemotherapy and Regimen.
While the research belongs to areas of Regimen, David S. Alberts spends his time largely on the problem of Taxane, intersecting his research to questions surrounding Pharmacology.
His Randomized controlled trial study deals with the bigger picture of Surgery.
The concepts of his Ovarian cancer study are interwoven with issues in Carboplatin, Quality of life, Isoflavones and Gynecology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
